| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Patel Naimish is a Chief Medical Officer at CRSP. Recent filings cover 0 purchases and 3 sales. Those positions are worth an estimated $1.1M at current prices.
Patel Naimish's largest disclosed position is in CRSP as Chief Medical Officer, worth about $1.1M. The recent filings there lean toward selling, a net 10,868 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | CRSP Crispr Therapeutics AG | Chief Medical Officer | Sale+OE | 3,786 | $55.62 | $210,577.32 | -16.4% | - | - | |
| Mar 16, 2026 | CRSP Crispr Therapeutics AG | Chief Medical Officer | Sale+OE | 3,150 | $48.26 | $152,019.00 | -19.3% | +2.9% | - | |
| May 29, 2025 | CRSP Crispr Therapeutics AG | Chief Medical Officer | Sale+OE | 3,932 | $35.94 | $141,316.08 | -39.3% | +45.5% | - |